FDA Drug Application (021444) for RISPERDAL by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021444
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRISPERDAL
Active IngredientRISPERIDONE

Active IngredientCount
List of drugs with Active Ingredient RISPERIDONE3


Back to FDA Applications sponsored by JANSSEN PHARMS